Cutaneous adverse effects of antihypertensive medications among hypertensive patients in Enugu state, Nigeria
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20262837Keywords:
Antihypertensive drugs, Adverse cutaneous reactions, Awareness creationAbstract
Background: Antihypertensive drugs are widely used for managing hypertension, especially during this period of increasing prevalence in Nigeria, Africa, and around the world. This study aimed to determine the prevalence of adverse cutaneous drug reactions (ACDRs) to antihypertensives among patients with systemic hypertension. Like other medication classes, side effects can occur and may affect different body systems. The scarcity of data on the profile of ACDRs to antihypertensive medications in Nigeria, despite their growing use, necessitated this study. Cutaneous side effects, being easily visible, could serve as early warning signs to prevent life-threatening complications; therefore, it is important to study them and use the findings to enhance prescriber awareness.
Methods: This cross-sectional descriptive study was conducted at the cardiology clinic of the University of Nigeria Teaching Hospital (UNTH) in Enugu from January to December 2024, among consenting, eligible hypertensive patients. Adverse cutaneous reactions were identified using a medicine-induced symptom checklist and self-report, based on the modified findings of Ranugha and Betkemr.
Results: A total of 70 patients (37 females), aged 26 to 80 years, were studied. The prevalence of ACDRs to antihypertensive medications was 17%. The most common ACDRs to antihypertensive medications among these patients were pruritus (7%), photosensitivity (7%), eczema (5.6%), flushing (4.2%), and vasculitis (4.2%).
Conclusions: There are ACDRs to antihypertensive medications among Nigerians. Increasing awareness of these and potential drug alternatives among prescribers and patients will reduce drug-induced morbidity, leading to better compliance and health outcomes.
References
Edward IR, Aronson JK. Adverse drug reaction: definitions, diagnosis, and management. Lancet. 2000;356(9235):1255-9. DOI: https://doi.org/10.1016/S0140-6736(00)02799-9
MSD Manual. Adverse drug reactions. Available at: https://www.msdmanuals.com/professional//clinical-pharmacology/adverse-drug-reactions/adverse-drug-reactions&hl/=en-NG. Accessed on 06 June 2026.
Nayak S, Achaniya B. Adverse cutaneous drug reaction. Indian J Dermatol. 2008;53(1):2-8. DOI: https://doi.org/10.4103/0019-5154.39732
Upadhayai JB, Nangia AK, Mukhija RP, Misra M, Mohan L, Singh KK. Cutaneous reactions due to antihypertensive drugs. Indian J Dermatol. 2006;51:189-91. DOI: https://doi.org/10.4103/0019-5154.27982
Akinlua JT, Meakin R, Umsar AM, Freemantle N. Current prevalence pattern of hypertension in Nigeria: A systematic Review. PLOS One. 2015;10(10):e0140021. DOI: https://doi.org/10.1371/journal.pone.0140021
Odili AN, Chori BS, Danladi B, Nwakile PC, Okoye IC, Abdullahi U, et al. Prevalence, Awareness, Treatment and Control of Hypertension in Nigeria: Data from a Nationwide Survey 2017. Glob Heart. 2020;151(1):47. DOI: https://doi.org/10.5334/gh.848
Ezeala-Adikaibe BA, Mbadiwe CN, Okafor UH, Nwobodo UM, Okwara CC, Okoli CP, et al. Prevalence of hypertension in a rural community in southeastern Nigeria: an opportunity for early intervention. J Hum Hypertens. 2023;37(8):694-700. DOI: https://doi.org/10.1038/s41371-023-00833-x
Ajayi IO, Sowemimo IO, Akpa OM, Ossai NE. Prevalence of hypertension and associated factors among residents of Ibadan-North Local Government Area of Nigeria. Nig J Cardiol. 2016;13(1):67-75. DOI: https://doi.org/10.4103/0189-7969.165168
Ranugha PSS, Betkemr JB. Antihypertensive in dermatology Part II- cutaneous adverse reactions to antihypertensive drugs. Indian J Dermatol Venereol Leprol. 2018;84:137-47. DOI: https://doi.org/10.4103/ijdvl.IJDVL_992_16
Chattejee S, Ghosh AP, Barbhuiya J, Dey SK. Adverse cutaneous drug reactions. A one-year survey at a dermatology outpatient clinic of a tertiary care hospital. Indian J Pharmacol. 2006;38:429-31. DOI: https://doi.org/10.4103/0253-7613.28212
Ahmed AM, Pritchard S, Reichenberg J. A review of cutaneous drug eruptions. Clin Geriatr Med. 2013;29:527-45. DOI: https://doi.org/10.1016/j.cger.2013.01.008
Olowofela AO, Isah AO. Profile adverse effects of antihypertensive medicines in a Tertiary care clinic in Nigeria. Ann Afr. Med. 2017;16(3):114-9. DOI: https://doi.org/10.4103/aam.aam_6_17
Thestrup-Pedersen K. Adverse reactions in the skin from anti-hypertensive drugs. Dan Med Bull. 1987;12(34):3-5.
Sudhakar R, George MK, Yasaswini B, Sundararajan N, Ahamada SM. Adverse drug reactions associated with antihypertensive drugs and its management. IJPSR. 2016;7(3):898-903.
Ozturk G, Turk BG, Senturk B, Turkmen M, Kandiloglu G. Exanthematous drug eruption due to valsartan. Cutan Ocul Toxicol. 2012;31(4):335-7. DOI: https://doi.org/10.3109/15569527.2011.647179
Akbas A, Kilinc F. Analysis of the Patient with lichenoid drug reactions; a retrospective study. Med Sci Discovery. 2018;5(3):153-60. DOI: https://doi.org/10.36472/msd.v5i3.228
Kassy CW, Okeke CC, Ndu AC, Umeobieri AK. Prevalence of controlled blood pressure among hypertensive patients and determinants of hypertensive complications in a Nigerian population. Int J Med Health Dev. 2022;27(3):226-32. DOI: https://doi.org/10.4103/ijmh.IJMH_3_22
Talat H, Wahid Z, Mirza R. Cutaneous drug reactions to antihypertensive agents: A report from a single center in Pakistan. Iranian J Dermatol. 2012;15(6):122-6.
Bonnetblanc JM. Drug eruptions caused by beta-blockers. Ann Med Interne (Paris). 1984;135(8):639-41.
Rodenburg EM, Stricker BH, Visser LE. Sex differences in cardiovascular drug-induced adverse reactions causing hospital admissions. Br J Clin Pharmacol. 2012;74(6):1045-52. DOI: https://doi.org/10.1111/j.1365-2125.2012.04310.x
Downloads
Published
How to Cite
Issue
Section
